PARAMETERS OF THYMIDYLATE SYNTHETASE (TS) INHIBITION IN BLADDER-CARCINOMA AFTER INTRAVESICAL 5-FLUOROURACIL (5-FU) COMBINED WITH SYSTEMIC ALLOPURINOL PROTECTION

被引：0
|
作者：
SPEARS, CP
GUSTAVSSON, B
LEISSNER, KH
DANENBERG, PV
机构：
[1] UNIV SO CALIF,CTR COMPREHENS CANC,LOS ANGELES,CA 90033
[2] GOTHENBURG UNIV,OSTRA HOSP,DEPT SURG,S-41124 GOTHENBURG,SWEDEN
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1984年 / 25卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：166 / 166
页数：1
相关论文
共 42 条
  • [11] 5-FLUOROURACIL (5-FU) AFTER PRIMARY COMBINED FILTRATION SURGERY - A PROSPECTIVE, RANDOMIZED STUDY
    WONG, P
    GOLDENFELD, M
    RUDERMAN, J
    ROSENBERG, L
    KRUPIN, T
    SHIELDS, MB
    LIEBMANN, J
    RITCH, R
    GIESER, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (04) : 727 - 727
  • [12] THE EFFECTS OF 5-FLUOROURACIL (FU) ON MOUSE FM3A CELLS WITH HIGHLY AMPLIFIED THYMIDYLATE SYNTHETASE (TS) ACTIVITY
    DANENBERG, K
    DANENBERG, PV
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 322 - 322
  • [13] EFFECT OF 5-FLUOROURACIL (FU) ALONE AND IN COMBINATION WITH NORMAL METABOLITES ON THYMIDYLATE SYNTHETASE (TS) AND GROWTH IN CELL-CULTURE
    EVANS, RM
    HAKALA, MT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 154 - 154
  • [14] Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistance to 5-fluorouracil (5-FU) in human cancer xenografts in vivo
    Fukushima, M
    Fujioka, A
    Uchida, J
    Nakagawa, F
    Takechi, T
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (13) : 1681 - 1687
  • [15] Selective protection by uridine of growth inhibition by 5-fluorouracil (5FU) mediated by 5FU incorporation into RNA, but not the thymidylate synthase mediated growth inhibition by 5FU-leucovorin
    Codacci-Pisanelli, G.
    Noordhuis, P.
    van der Wilt, C. L.
    Peters, G. J.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2008, 27 (6-7): : 733 - 739
  • [16] Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma
    Toriumi, F
    Kubota, T
    Saikawa, Y
    Yoshida, M
    Otani, Y
    Watanabe, M
    Kumai, K
    Kitajima, M
    ANTICANCER RESEARCH, 2004, 24 (04) : 2455 - 2463
  • [17] Reduction of 5-fluorouracil (5-FU) gastrointestinal (GI) toxicity resulting from the protection of thymidylate synthase (TS) in GI tissue by repeated simultaneous administration of potassium oxonate (Oxo) in rats
    Yoshisue, K
    Hironaga, K
    Yamaguchi, S
    Yamamoto, A
    Nagayama, S
    Kawaguchi, Y
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (01) : 51 - 56
  • [18] Reduction of 5-fluorouracil (5-FU) gastrointestinal (GI) toxicity resulting from the protection of thymidylate synthase (TS) in GI tissue by repeated simultaneous administration of potassium oxonate (Oxo) in rats
    Kunihiro Yoshisue
    Kazue Hironaga
    Syuji Yamaguchi
    Akira Yamamoto
    Sekio Nagayama
    Yasuro Kawaguchi
    Cancer Chemotherapy and Pharmacology, 2000, 46 : 51 - 56
  • [19] COMBINED 5-FLUOROURACIL (5-FU) AND RADIATION-THERAPY FOLLOWING RESECTION OF LOCALLY ADVANCED GASTRIC-CARCINOMA
    GEZ, E
    SULKES, A
    YABLONSKYPERETZ, T
    WESHLER, Z
    JOURNAL OF SURGICAL ONCOLOGY, 1986, 31 (02) : 139 - 142
  • [20] EVALUATION OF HIGH DOSE RADIATION AND COMBINED RADIATION AND 5-FLUOROURACIL (5-FU) THERAPY FOR LOCALLY UNRESECTABLE PANCREATIC CARCINOMA
    MOERTEL, CG
    LOKICH, JJ
    CHILDS, DS
    SCHEIN, PS
    LAVIN, PT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 244 - 244
12345